Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure

Background: According to numerous studies, from 30% to 50% of patients with chronic heart failure (CHF) are resistant to cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM), despite their careful selection in accordance with current guidelines. It is of interest to stu...

Descripció completa

Dades bibliogràfiques

Autors principals:	N. B. Shlevkov, A. Zh. Gasparyan, A. A. Zhambeev, H. F. Salami, E. V. Guseva, G. S. Tarasovskiy, T. V. Sharf, O. V. Stukalova, E. M. Gupalo, N. A. Mironova, A. A. Skvortsov, S. P. Golitsyn
Format:	Artigo
Idioma:	Russo
Publicat:	MONIKI 2021-06-01
Col·lecció:	Alʹmanah Kliničeskoj Mediciny
Matèries:	biomarkers nt-probnp sst2 chronic heart failure cardiac resynchronization therapy cardiac contractility modulation prognosis
Accés en línia:	https://www.almclinmed.ru/jour/article/view/1487
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!